Historical annual and monthly returns for AbbVie (ABBV).
For AbbVie (ABBV), the strongest completed calendar year was 2017, when the stock returned 60.1%, while its weakest was 2015, with a return of -6.5%. Across the 12 completed calendar years from 2014 through 2025, its average annual return was 19.0% and its compounded annual return was 17.6%. ABBV posted positive returns in 9 of those 12 years (75%). In 2025, the latest completed year, it returned 33.1%. In 2026 year to date, ABBV has returned 19.4%.
Returns are calculated from the adjusted daily closing prices for AbbVie (ABBV). Annual returns measure the percentage change between the final available trading prices of consecutive calendar years. Monthly returns use the corresponding month-end observations. Adjusted prices account for stock splits and distributions when supplied by the market-data provider. Results are nominal and are not adjusted for inflation.
